{"entity":{"type":"insider","cik":"0001346164","url":"/insider/0001346164","json_url":"/insider/0001346164.json","name":"Simpson Curran","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":70,"n_filings":32,"first":"2009-08-10","last":"2025-10-10","span_basis":"filed_date"},"name_variants":[{"name":"Simpson Curran","source":"filing","n_filings":32,"first_seen":"2009-08-10","last_seen":"2025-10-10"}],"transactions":[{"id":4107102,"accession":"0001346164-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346164-25-000005","line_url":"/filing/0001346164-25-000005#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20811.0,"shares_display":"20,811","price_per_share":12.62,"price_display":"12.62","price_state":"stated","total_value":262634.82,"total_display":"262,634.82","shares_owned_after":216162.0,"shares_owned_after_display":"216,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-10","scope":"insider"},{"id":4279955,"accession":"0001346164-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346164-25-000003","line_url":"/filing/0001346164-25-000003#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7624.0,"shares_display":"7,624","price_per_share":10.03,"price_display":"10.03","price_state":"stated","total_value":76468.72,"total_display":"76,468.72","shares_owned_after":236973.0,"shares_owned_after_display":"236,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":4402528,"accession":"0001562180-25-006194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-006194","line_url":"/filing/0001562180-25-006194#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7734.0,"shares_display":"7,734","price_per_share":10.02,"price_display":"10.02","price_state":"stated","total_value":77494.68,"total_display":"77,494.68","shares_owned_after":244597.0,"shares_owned_after_display":"244,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider"},{"id":2113947,"accession":"0001562180-24-006014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-006014","line_url":"/filing/0001562180-24-006014#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","shares_owned_after":170037.0,"shares_owned_after_display":"170,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":2967434,"accession":"0001562180-24-005874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005874","line_url":"/filing/0001562180-24-005874#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9648.0,"shares_display":"9,648","price_per_share":15.04,"price_display":"15.04","price_state":"stated","total_value":145105.92,"total_display":"145,105.92","shares_owned_after":170137.0,"shares_owned_after_display":"170,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-30","scope":"insider"},{"id":4521818,"accession":"0001562180-21-000345","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-21-000345","line_url":"/filing/0001562180-21-000345#line-5","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Chief Oper. & Tech. Officer)","officer_title":"Chief Oper. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11612.0,"shares_display":"11,612","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":580716.12,"total_display":"580,716.12","shares_owned_after":17748.0,"shares_owned_after_display":"17,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-14","scope":"insider"},{"id":4521811,"accession":"0001562180-21-000345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-000345","line_url":"/filing/0001562180-21-000345#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Chief Oper. & Tech. Officer)","officer_title":"Chief Oper. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":50.03,"price_display":"50.03","price_state":"stated","total_value":85051.0,"total_display":"85,051.00","shares_owned_after":17748.0,"shares_owned_after_display":"17,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-14","scope":"insider"},{"id":4421442,"accession":"0001562180-21-000284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-000284","line_url":"/filing/0001562180-21-000284#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Chief Oper. & Tech. Officer)","officer_title":"Chief Oper. & Tech. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5185.0,"shares_display":"5,185","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":259301.85,"total_display":"259,301.85","shares_owned_after":17748.0,"shares_owned_after_display":"17,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-11","scope":"insider"},{"id":3224723,"accession":"0001562180-20-001112","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-20-001112","line_url":"/filing/0001562180-20-001112#line-7","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8872.0,"shares_display":"8,872","price_per_share":50.13,"price_display":"50.13","price_state":"stated","total_value":444753.36,"total_display":"444,753.36","shares_owned_after":7640.0,"shares_owned_after_display":"7,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":3224712,"accession":"0001562180-20-001112","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-20-001112","line_url":"/filing/0001562180-20-001112#line-6","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3692.0,"shares_display":"3,692","price_per_share":51.37,"price_display":"51.37","price_state":"stated","total_value":189658.04,"total_display":"189,658.04","shares_owned_after":3948.0,"shares_owned_after_display":"3,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":3224701,"accession":"0001562180-20-001112","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-001112","line_url":"/filing/0001562180-20-001112#line-4","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44429.0,"shares_display":"44,429","price_per_share":50.22,"price_display":"50.22","price_state":"stated","total_value":2231224.38,"total_display":"2,231,224.38","shares_owned_after":9879.0,"shares_owned_after_display":"9,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":2238867,"accession":"0001562180-20-001015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-001015","line_url":"/filing/0001562180-20-001015#line-5","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5637.0,"shares_display":"5,637","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":281850.0,"total_display":"281,850.00","shares_owned_after":22648.0,"shares_owned_after_display":"22,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider"},{"id":2530446,"accession":"0001562180-20-000454","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-000454","line_url":"/filing/0001562180-20-000454#line-4","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5922.0,"shares_display":"5,922","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":296100.0,"total_display":"296,100.00","shares_owned_after":23148.0,"shares_owned_after_display":"23,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-17","filed_date":"2020-01-21","scope":"insider"},{"id":7987071,"accession":"0001562180-19-006017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-006017","line_url":"/filing/0001562180-19-006017#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9399.0,"shares_display":"9,399","price_per_share":43.4,"price_display":"43.40","price_state":"stated","total_value":407916.6,"total_display":"407,916.60","shares_owned_after":30101.0,"shares_owned_after_display":"30,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7987066,"accession":"0001562180-19-006017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-006017","line_url":"/filing/0001562180-19-006017#line-1","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6153.0,"shares_display":"6,153","price_per_share":44.26,"price_display":"44.26","price_state":"stated","total_value":272331.78,"total_display":"272,331.78","shares_owned_after":23948.0,"shares_owned_after_display":"23,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7902992,"accession":"0001562180-19-003180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-003180","line_url":"/filing/0001562180-19-003180#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":7902837,"accession":"0001562180-19-001472","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-001472","line_url":"/filing/0001562180-19-001472#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":54.05,"price_display":"54.05","price_state":"stated","total_value":286465.0,"total_display":"286,465.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8577366,"accession":"0001562180-19-000815","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-19-000815","line_url":"/filing/0001562180-19-000815#line-5","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Product Development & CTO)","officer_title":"SVP, Product Development & CTO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43832.0,"shares_display":"43,832","price_per_share":50.08,"price_display":"50.08","price_state":"stated","total_value":2195106.56,"total_display":"2,195,106.56","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":6889743,"accession":"0001562180-18-004631","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-18-004631","line_url":"/filing/0001562180-18-004631#line-5","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15494.0,"shares_display":"15,494","price_per_share":64.71,"price_display":"64.71","price_state":"stated","total_value":1002616.74,"total_display":"1,002,616.74","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-20","scope":"insider"},{"id":6889739,"accession":"0001562180-18-004631","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-18-004631","line_url":"/filing/0001562180-18-004631#line-4","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6883.0,"shares_display":"6,883","price_per_share":62.79,"price_display":"62.79","price_state":"stated","total_value":432183.57,"total_display":"432,183.57","shares_owned_after":61499.0,"shares_owned_after_display":"61,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-20","scope":"insider"},{"id":6889736,"accession":"0001562180-18-004631","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-004631","line_url":"/filing/0001562180-18-004631#line-3","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6505.0,"shares_display":"6,505","price_per_share":63.64,"price_display":"63.64","price_state":"stated","total_value":413978.2,"total_display":"413,978.20","shares_owned_after":54994.0,"shares_owned_after_display":"54,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-20","scope":"insider"},{"id":6889733,"accession":"0001562180-18-004631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004631","line_url":"/filing/0001562180-18-004631#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":61.91,"price_display":"61.91","price_state":"stated","total_value":247640.0,"total_display":"247,640.00","shares_owned_after":68382.0,"shares_owned_after_display":"68,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-20","scope":"insider"},{"id":6739291,"accession":"0001562180-18-004249","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-18-004249","line_url":"/filing/0001562180-18-004249#line-6","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46517.0,"shares_display":"46,517","price_per_share":60.85,"price_display":"60.85","price_state":"stated","total_value":2830559.45,"total_display":"2,830,559.45","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-18","scope":"insider"},{"id":6739288,"accession":"0001562180-18-004249","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-18-004249","line_url":"/filing/0001562180-18-004249#line-5","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13125.0,"shares_display":"13,125","price_per_share":60.85,"price_display":"60.85","price_state":"stated","total_value":798656.25,"total_display":"798,656.25","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-18","scope":"insider"},{"id":6739285,"accession":"0001562180-18-004249","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-18-004249","line_url":"/filing/0001562180-18-004249#line-4","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2667.0,"shares_display":"2,667","price_per_share":60.85,"price_display":"60.85","price_state":"stated","total_value":162286.95,"total_display":"162,286.95","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-18","scope":"insider"},{"id":6160178,"accession":"0001562180-18-001641","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001641","line_url":"/filing/0001562180-18-001641#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":825000.0,"total_display":"825,000.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":5163330,"accession":"0001562180-17-004033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-004033","line_url":"/filing/0001562180-17-004033#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":33.03,"price_display":"33.03","price_state":"stated","total_value":990900.0,"total_display":"990,900.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":4318582,"accession":"0001562180-17-003824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-17-003824","line_url":"/filing/0001562180-17-003824#line-3","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21890.0,"shares_display":"21,890","price_per_share":30.04,"price_display":"30.04","price_state":"stated","total_value":657575.6,"total_display":"657,575.60","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-11","scope":"insider"},{"id":4790919,"accession":"0001562180-17-003752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-003752","line_url":"/filing/0001562180-17-003752#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":3300.0,"total_display":"3,300.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-06","scope":"insider"},{"id":4466849,"accession":"0001562180-17-003689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-003689","line_url":"/filing/0001562180-17-003689#line-2","is_derivative":false,"issuer_cik":"0001346164","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001346164","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (SVP, Technical Operations)","officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":29.31,"price_display":"29.31","price_state":"stated","total_value":58620.0,"total_display":"58,620.00","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-27","filed_date":"2017-11-29","scope":"insider"},{"id":8840010,"accession":"0001225208-11-015740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-015740","line_url":"/filing/0001225208-11-015740#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22904.0,"shares_display":"22,904","price_per_share":27.1114,"price_display":"27.11","price_state":"stated","total_value":620959.5056,"total_display":"620,959.51","shares_owned_after":45790.0,"shares_owned_after_display":"45,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-02","scope":"insider"},{"id":8890187,"accession":"0001225208-11-012698","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-11-012698","line_url":"/filing/0001225208-11-012698#line-3","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28015.0,"shares_display":"28,015","price_per_share":28.9855,"price_display":"28.99","price_state":"stated","total_value":812028.7825,"total_display":"812,028.78","shares_owned_after":45790.0,"shares_owned_after_display":"45,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-29","filed_date":"2011-05-02","scope":"insider"},{"id":7532418,"accession":"0001225208-10-021808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-021808","line_url":"/filing/0001225208-10-021808#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22903.0,"shares_display":"22,903","price_per_share":29.7948,"price_display":"29.79","price_state":"stated","total_value":682390.3044,"total_display":"682,390.30","shares_owned_after":25281.0,"shares_owned_after_display":"25,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-01","filed_date":"2010-10-04","scope":"insider"},{"id":7671220,"accession":"0001209191-10-044188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-044188","line_url":"/filing/0001209191-10-044188#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18461.0,"shares_display":"18,461","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":516908.0,"total_display":"516,908.00","shares_owned_after":25281.0,"shares_owned_after_display":"25,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-25","filed_date":"2010-08-27","scope":"insider"},{"id":7224111,"accession":"0001225208-10-015100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-015100","line_url":"/filing/0001225208-10-015100#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18461.0,"shares_display":"18,461","price_per_share":26.066,"price_display":"26.07","price_state":"stated","total_value":481204.426,"total_display":"481,204.43","shares_owned_after":25281.0,"shares_owned_after_display":"25,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-11","filed_date":"2010-06-14","scope":"insider"},{"id":7443196,"accession":"0001225208-10-010244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-010244","line_url":"/filing/0001225208-10-010244#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":32.7571,"price_display":"32.76","price_state":"stated","total_value":982713.0,"total_display":"982,713.00","shares_owned_after":25281.0,"shares_owned_after_display":"25,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-12","filed_date":"2010-04-12","scope":"insider"},{"id":7140121,"accession":"0001225208-10-004538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-004538","line_url":"/filing/0001225208-10-004538#line-2","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":29.1034,"price_display":"29.10","price_state":"stated","total_value":873102.0,"total_display":"873,102.00","shares_owned_after":11112.0,"shares_owned_after_display":"11,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-16","scope":"insider"},{"id":7640414,"accession":"0001225208-10-001397","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-16","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":30.85,"price_display":"30.85","price_state":"stated","total_value":141910.0,"total_display":"141,910.00","shares_owned_after":11112.0,"shares_owned_after_display":"11,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640412,"accession":"0001225208-10-001397","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-15","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4524.0,"shares_display":"4,524","price_per_share":30.5771,"price_display":"30.58","price_state":"stated","total_value":138330.8004,"total_display":"138,330.80","shares_owned_after":15712.0,"shares_owned_after_display":"15,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640410,"accession":"0001225208-10-001397","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-14","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4104.0,"shares_display":"4,104","price_per_share":30.7078,"price_display":"30.71","price_state":"stated","total_value":126024.8112,"total_display":"126,024.81","shares_owned_after":20236.0,"shares_owned_after_display":"20,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640408,"accession":"0001225208-10-001397","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-13","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3872.0,"shares_display":"3,872","price_per_share":30.5561,"price_display":"30.56","price_state":"stated","total_value":118313.2192,"total_display":"118,313.22","shares_owned_after":24340.0,"shares_owned_after_display":"24,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640406,"accession":"0001225208-10-001397","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-12","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":30.6806,"price_display":"30.68","price_state":"stated","total_value":98177.92,"total_display":"98,177.92","shares_owned_after":28212.0,"shares_owned_after_display":"28,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640404,"accession":"0001225208-10-001397","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-11","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2761.0,"shares_display":"2,761","price_per_share":30.8008,"price_display":"30.80","price_state":"stated","total_value":85041.0088,"total_display":"85,041.01","shares_owned_after":31412.0,"shares_owned_after_display":"31,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640402,"accession":"0001225208-10-001397","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-10","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2488.0,"shares_display":"2,488","price_per_share":30.54,"price_display":"30.54","price_state":"stated","total_value":75983.52,"total_display":"75,983.52","shares_owned_after":34173.0,"shares_owned_after_display":"34,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640400,"accession":"0001225208-10-001397","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-9","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":30.531,"price_display":"30.53","price_state":"stated","total_value":51902.7,"total_display":"51,902.70","shares_owned_after":36661.0,"shares_owned_after_display":"36,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640398,"accession":"0001225208-10-001397","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-8","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1361.0,"shares_display":"1,361","price_per_share":30.82,"price_display":"30.82","price_state":"stated","total_value":41946.02,"total_display":"41,946.02","shares_owned_after":38361.0,"shares_owned_after_display":"38,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640396,"accession":"0001225208-10-001397","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-7","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1335.0,"shares_display":"1,335","price_per_share":30.5602,"price_display":"30.56","price_state":"stated","total_value":40797.867,"total_display":"40,797.87","shares_owned_after":39722.0,"shares_owned_after_display":"39,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640393,"accession":"0001225208-10-001397","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-6","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":30.7654,"price_display":"30.77","price_state":"stated","total_value":39995.02,"total_display":"39,995.02","shares_owned_after":41057.0,"shares_owned_after_display":"41,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640391,"accession":"0001225208-10-001397","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-5","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":30.89,"price_display":"30.89","price_state":"stated","total_value":24712.0,"total_display":"24,712.00","shares_owned_after":42357.0,"shares_owned_after_display":"42,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"},{"id":7640390,"accession":"0001225208-10-001397","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-10-001397","line_url":"/filing/0001225208-10-001397#line-4","is_derivative":false,"issuer_cik":"0000901219","issuer_name":"HUMAN GENOME SCIENCES INC","issuer_ticker":"HGSI","issuer_name_source":null,"issuer_url":"/issuer/0000901219","owner_cik":"0001346164","owner_name":"Simpson Curran","owner_url":"/insider/0001346164","role":"Officer (Sr. VP, Operations)","officer_title":"Sr. VP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":628.0,"shares_display":"628","price_per_share":30.56,"price_display":"30.56","price_state":"stated","total_value":19191.68,"total_display":"19,191.68","shares_owned_after":43157.0,"shares_owned_after_display":"43,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-12","scope":"insider"}],"next_cursor":"2010-01-11|7640390","ledger_fault":false,"count":{"value":70,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":70,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":70},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001590877","name":"REGENXBIO Inc.","url":"/issuer/0001590877","role":"Director, Officer (Chief Executive Officer)","n_filings":21,"first_seen":"2017-11-29","last_seen":"2025-10-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000901219","name":"HUMAN GENOME SCIENCES INC","url":"/issuer/0000901219","role":"Officer (Sr. VP, Operations)","n_filings":11,"first_seen":"2009-08-10","last_seen":"2011-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346164","retrieved_at":"2026-08-21T18:52:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}